KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Non-Current Debt (2019 - 2025)

GoodRx Holdings (GDRX) has disclosed Non-Current Debt for 7 consecutive years, with $483.3 million as the latest value for Q4 2025.

  • Quarterly Non-Current Debt fell 0.71% to $483.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $483.3 million through Dec 2025, down 0.71% year-over-year, with the annual reading at $483.3 million for FY2025, 0.71% down from the prior year.
  • Non-Current Debt hit $483.3 million in Q4 2025 for GoodRx Holdings, roughly flat from $484.1 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $658.9 million in Q1 2021 to a low of $483.3 million in Q4 2025.
  • Historically, Non-Current Debt has averaged $602.2 million across 5 years, with a median of $649.2 million in 2023.
  • Biggest five-year swings in Non-Current Debt: fell 0.61% in 2021 and later decreased 24.89% in 2025.
  • Year by year, Non-Current Debt stood at $655.9 million in 2021, then fell by 0.62% to $651.8 million in 2022, then fell by 0.63% to $647.7 million in 2023, then fell by 24.86% to $486.7 million in 2024, then decreased by 0.71% to $483.3 million in 2025.
  • Business Quant data shows Non-Current Debt for GDRX at $483.3 million in Q4 2025, $484.1 million in Q3 2025, and $485.0 million in Q2 2025.